DOCK9-DT: A Drug Target / Disease Biomarker (G100861541)

Target Name: DOCK9-DT

NCBI ID: G100861541

Other Name(s): DOCK9 divergent transcript | DOCK9-AS2

DOCK9-DT: A Drug Target / Disease Biomarker

DOCK9-DT is a protein that is expressed in the brain and is involved in the development and progression of various neurological disorders, including Alzheimer's disease. It is a key regulator of the microtubules, which are the building blocks of the neuronal cytoskeleton and play a crucial role in the movement and communication of cells in the brain.

Research has shown that DOCK9-DT is involved in the regulation of a wide range of cellular processes, including the assembly and disassembly of microtubules, the transport of vesicles and organelles within cells, and the regulation of ion channels and signaling pathways. It is also involved in the regulation of cell survival and in the development of neurodegenerative diseases.

One of the key challenges in studying DOCK9-DT is its complex and highly regulated structure. The protein is composed of several hundred amino acid residues and is expressed in a variety of tissues and cells, including the brain. It is highly glycophosphorylated, which means that it has several glycyl groups on its surface that can interact with other molecules and contribute to its stability and function.

The structure and function of DOCK9-DT are closely related to the regulation of microtubule dynamics and the development of neurodegenerative diseases. Microtubules are the building blocks of the neuronal cytoskeleton and are responsible for the movement and communication of cells in the brain. They are constantly in motion and are able to change their shape and structure in response to various stimuli. The regulation of microtubule dynamics is critical for the proper functioning of cells and is involved in the development and progression of a wide range of neurological disorders, including Alzheimer's disease.

DOCK9-DT is involved in the regulation of microtubule dynamics by controlling the assembly and disassembly of microtubules. It does this by interacting with a variety of different molecules, including the protein tau and the nucleotide GDP. Tau is a protein that is involved in the regulation of microtubule stability and is often mutated in Alzheimer's disease. GDP is a nucleotide that is bound to the microtubules and is involved in the regulation of microtubule dynamics.

In addition to its role in the regulation of microtubule dynamics, DOCK9-DT is also involved in the regulation of ion channels and signaling pathways. It does this by interacting with a variety of different molecules, including the protein syntaxin and the nucleotide GTP. syntaxin is a protein that is involved in the regulation of ion channels in the brain and is often mutated in epilepsy and other neurological disorders. GTP is a nucleotide that is involved in the regulation of many different cellular processes, including the regulation of microtubule dynamics.

The regulation of DOCK9-DT by GTP is a critical factor in the development of neurodegenerative diseases. GTP is able to interact with DOCK9-DT and regulate the stability of the protein, which is involved in the regulation of microtubule dynamics. If GTP is unable to interact with DOCK9-DT, the protein is less stable and is less able to regulate microtubule dynamics, which can lead to the development of neurodegenerative diseases.

In conclusion, DOCK9-DT is a protein that is involved in the regulation of microtubule dynamics and the development and progression of various neurological disorders, including Alzheimer's disease. It is a key regulator of the microtubules and is involved in the assembly and disassembly of microtubules, as well as the regulation of ion channels and signaling pathways. The regulation of DOCK9-DT by GTP is a critical factor in the development of neurodegenerative diseases and is an attractive target for drug development.

Protein Name: DOCK9 Divergent Transcript

More Common Targets